Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Enlivex Therapeutics (ENLV) Short Interest Ratio & Short Volume

Enlivex Therapeutics logo
$0.70 -0.02 (-3.23%)
Closing price 05/18/2026 04:00 PM Eastern
Extended Trading
$0.70 +0.00 (+0.53%)
As of 05:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Enlivex Therapeutics Short Interest Overview

As of April 30, 2026, Enlivex Therapeutics (ENLV) had a short interest of 534,224 shares sold short, representing 0.26% of the public float. This marks a -1.98% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.1, meaning it would take 1.1 days of the average trading volume of 297,608 shares to cover all short positions.

Current Short Interest
534,224 shares
Previous Short Interest
545,016 shares
Change Vs. Previous Month
-1.98%
Dollar Volume Sold Short
$437.96 thousand
Short Interest Ratio
1.1 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
237,380,000 shares
Short Percent of Float
0.26%
Today's Trading Volume
124,948 shares
Average Trading Volume
297,608 shares
Today's Volume Vs. Average
42%
Short Selling Enlivex Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Enlivex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ENLV Short Interest Over Time

ENLV Days to Cover Over Time

ENLV Percentage of Float Shorted Over Time

Enlivex Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026534,224 shares $437.96 thousand -2.0%0.3%1.13 $0.82
4/15/2026545,016 shares $446.91 thousand +1.9%0.3%0.92 $0.82
3/31/2026535,106 shares $497.70 thousand +3.7%0.3%0.44 $0.93
3/13/2026515,954 shares $536.59 thousand -8.5%0.2%3.1 $1.04
2/27/2026563,947 shares $648.54 thousand +8.1%0.3%2.95 $1.15
2/13/2026521,667 shares $579.05 thousand -0.9%0.3%1.43 $1.11
1/30/2026526,156 shares $531.42 thousand +160.9%0.3%1.09 $1.01
1/15/2026201,697 shares $188.34 thousand -66.6%0.1%0.44 $0.93
12/31/2025603,238 shares $424.20 thousand +158.4%0.3%1.05 $0.70
12/15/2025233,417 shares $200.97 thousand -79.7%1.1%0.21 $0.86
11/28/20251,147,847 shares $1.07 million +573.6%5.4%0.05 $0.94
11/14/2025170,414 shares $168.93 thousand +92.0%0.8%1.82 $0.99
10/31/202588,743 shares $93.18 thousand -48.8%0.4%0.6 $1.05
10/15/2025173,200 shares $200.91 thousand -34.5%0.8%0.3 $1.16
9/30/2025264,400 shares $274.98 thousand -14.8%N/A0.5 $1.04
9/15/2025310,400 shares $330.58 thousand +16.7%N/A0.6 $1.07
8/31/2025266,100 shares $279.41 thousand +413.7%1.3%0.5 $1.05
8/15/202551,800 shares $94.28 thousand -73.6%N/A0.1 $1.82
7/31/2025196,500 shares $292.79 thousand -33.3%0.9%1.2 $1.49
7/15/2025294,400 shares $362.11 thousand +51.7%N/A3.6 $1.23
6/30/2025194,100 shares $217.39 thousand +157.8%0.9%2.6 $1.12
6/15/202575,300 shares $68.15 thousand -23.6%0.4%1.1 $0.91
5/31/202598,600 shares $94.99 thousand -18.8%0.5%1.3 $0.96
5/15/2025121,400 shares $125.04 thousand -11.3%0.6%1 $1.03
4/30/2025136,900 shares $139.64 thousand +43.1%N/A1.1 $1.02
4/15/202595,700 shares $85.32 thousand -8.3%0.5%0.8 $0.89
3/31/2025104,400 shares $101.29 thousand -17.9%0.6%0.8 $0.97
3/15/2025127,100 shares $155.06 thousand +11.0%0.7%0.9 $1.22
2/28/2025114,500 shares $137.40 thousand +8.9%0.6%0.5 $1.20
2/15/2025105,100 shares $110.36 thousand -11.5%0.6%0.5 $1.05
1/31/2025118,800 shares $130.68 thousand -3.4%N/A0.6 $1.10
1/15/2025123,000 shares $141.45 thousand -1.8%N/A0.5 $1.15
12/31/2024125,200 shares $146.48 thousand -41.2%N/A0.5 $1.17
12/15/2024212,900 shares $255.48 thousand -0.9%N/A0.9 $1.20
11/30/2024214,800 shares $244.87 thousand +116.5%N/A0.9 $1.14
11/15/202499,200 shares $106.14 thousand -38.0%N/A0.7 $1.07
10/31/2024160,100 shares $216.14 thousand +58.7%N/A1.4 $1.35
10/15/2024100,900 shares $156.40 thousand -3.5%N/A1.1 $1.55
9/30/2024104,600 shares $175.73 thousand -23.1%N/A1.4 $1.68
9/15/2024136,100 shares $213.68 thousand +43.9%N/A1.9 $1.57
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

See the 5 stocks to avoid
8/31/202494,600 shares $122.98 thousand +26.6%N/A1.9 $1.30
8/15/202474,700 shares $91.13 thousand -11.7%N/A1.3 $1.22
7/31/202484,600 shares $113.36 thousand -27.4%N/A1.4 $1.34
7/15/2024116,500 shares $164.27 thousand -0.6%N/A1.6 $1.41
6/30/2024117,200 shares $166.42 thousand -16.8%N/A0.7 $1.42
6/15/2024140,800 shares $205.57 thousand -10.5%N/A0.8 $1.46
5/31/2024157,300 shares $213.93 thousand -31.8%N/A0.9 $1.36
5/15/2024230,600 shares $327.45 thousand -12.4%N/A1.3 $1.42
4/30/2024263,200 shares $439.54 thousand -5.6%N/A1.5 $1.67
4/15/2024278,700 shares $362.31 thousand +17.9%N/A1.6 $1.30
3/31/2024236,400 shares $895.96 thousand -9.6%N/A2.7 $3.79
3/15/2024261,500 shares $1.07 million +15.4%N/A2.4 $4.11
2/29/2024226,600 shares $703.59 thousand +51.2%N/A2.2 $3.11
2/15/2024149,900 shares $481.18 thousand -6.6%N/A1.6 $3.21
1/31/2024160,500 shares $449.40 thousand -13.7%N/A1.9 $2.80
1/15/2024185,900 shares $533.53 thousand +32.5%N/A2.3 $2.87
12/31/2023140,300 shares $378.81 thousand +36.0%N/A1.8 $2.70
12/15/2023103,200 shares $145.51 thousand -6.3%N/A1.9 $1.41
11/30/2023110,100 shares $202.58 thousand -0.9%N/A3.5 $1.84
11/15/2023111,100 shares $194.43 thousand -6.2%N/A3.6 $1.75
10/31/2023118,400 shares $157.47 thousand +13.1%N/A3.9 $1.33
10/15/2023104,700 shares $147.63 thousand -8.1%N/A4.1 $1.41
9/30/2023113,900 shares $179.96 thousand +4.4%N/A4.5 $1.58
9/15/2023109,100 shares $206.20 thousand +3.4%N/A4.2 $1.89
8/31/2023105,500 shares $252.15 thousand -9.3%N/A4.8 $2.39
8/15/2023116,300 shares $303.54 thousand +2.4%N/A5.1 $2.61
7/31/2023113,600 shares $290.82 thousand +8.6%N/A4.9 $2.56
7/15/2023104,600 shares $248.95 thousand +2.5%N/A4.8 $2.38
6/30/2023102,100 shares $268.25 thousand -20.2%N/A3.6 $2.63
6/15/2023128,000 shares $362.24 thousand +5.6%N/A3.6 $2.83
5/31/2023121,200 shares $316.33 thousand -5.8%N/A3.5 $2.61
5/15/2023128,700 shares $359.07 thousand -1.2%N/A3.8 $2.79
4/30/2023130,200 shares $369.77 thousand -4.6%N/A3.7 $2.84
4/15/2023136,400 shares $396.92 thousand -15.7%N/A3.6 $2.91
3/31/2023161,700 shares $588.59 thousand +0.5%N/A4.3 $3.64
3/15/2023160,900 shares $577.63 thousand -1.3%N/A5.9 $3.59
2/28/2023163,000 shares $652 thousand +0.9%N/A5.7 $4.00
2/15/2023161,500 shares $673.46 thousand -8.8%N/A5.5 $4.17
1/31/2023177,100 shares $775.70 thousand -2.9%N/A5.8 $4.38
1/15/2023182,300 shares $796.51 thousand -4.8%N/A6.9 $4.37
12/30/2022191,400 shares $753.64 thousand -0.5%N/A7.8 $3.94
12/15/2022192,400 shares $779.22 thousand -11.5%N/A9.2 $4.05
11/30/2022217,500 shares $997.00 thousand +16.9%N/A9 $4.58
11/15/2022186,000 shares $894.66 thousand +0.1%N/A6.9 $4.81
10/31/2022185,800 shares $797.08 thousand -3.8%N/A6.6 $4.29
10/15/2022193,100 shares $805.23 thousand +1.2%N/A5.4 $4.17
9/30/2022190,900 shares $811.33 thousand +4.5%N/A4.4 $4.25
9/15/2022182,700 shares $959.18 thousand -5.4%N/A3.9 $5.25
8/31/2022193,100 shares $1.01 million -7.0%N/A4.2 $5.25
8/15/2022207,700 shares $1.08 million -9.5%N/A4.4 $5.22
Iran's New Leader Just Said Something That Should Terrify Every American (Ad)

Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.tc pixel

Claim your free copy of The Great Gold Reset report today
7/31/2022229,600 shares $975.80 thousand -8.4%N/A4 $4.25
7/15/2022250,600 shares $1.23 million -9.8%N/A3.8 $4.91
6/30/2022277,700 shares $1.26 million -2.3%N/A3.5 $4.52
6/15/2022284,300 shares $1.16 million -0.3%N/A3.5 $4.07
5/31/2022285,000 shares $1.43 million -9.2%N/A3.5 $5.01
5/15/2022313,900 shares $1.34 million -9.6%N/A4.1 $4.28
4/30/2022347,200 shares $1.98 million -3.9%N/A4.7 $5.69
4/15/2022361,300 shares $2.67 million +15.0%N/A5.9 $7.39
3/31/2022314,200 shares $1.76 million -2.2%N/A5.3 $5.59
3/15/2022321,300 shares $1.63 million -10.4%N/A5.3 $5.06
2/28/2022358,500 shares $1.92 million -4.0%N/A4.9 $5.35
2/15/2022373,500 shares $1.99 million +2.8%N/A4.7 $5.34
1/31/2022363,200 shares $1.94 million +8.2%N/A4.2 $5.34
1/15/2022335,700 shares $1.97 million -8.3%N/A3.7 $5.87
12/31/2021365,900 shares $2.29 million +0.1%N/A4.2 $6.25
12/15/2021365,400 shares $2.40 million -3.6%N/A4.4 $6.56
11/30/2021379,000 shares $2.65 million +7.0%N/A5 $7.00
11/15/2021354,200 shares $2.91 million +9.9%N/A3.5 $8.21
10/29/2021322,200 shares $2.65 million +4.5%N/A1 $8.24
10/15/2021308,300 shares $2.86 million -13.0%N/A0.9 $9.28
9/30/2021354,300 shares $3.50 million -8.0%N/A1.1 $9.88
9/15/2021385,200 shares $4.21 million -8.0%N/A1.2 $10.92
8/31/2021418,500 shares $5.80 million +114.2%N/A1.3 $13.86
8/13/2021195,400 shares $1.99 million +38.0%N/A0.7 $10.17
7/30/2021141,600 shares $1.08 million No Change1.2%2.1 $7.60
7/15/2021141,600 shares $1.07 million +0.9%1.2%1.8 $7.54
6/30/2021140,400 shares $1.25 million +4.0%1.2%1.6 $8.90
6/15/2021135,000 shares $1.32 million +14.9%1.1%1.5 $9.80
5/28/2021117,500 shares $1.10 million -28.6%1.0%1.1 $9.37

ENLV Short Interest - Frequently Asked Questions

Short interest is the volume of Enlivex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 534,224 shares of ENLV short. 0.26% of Enlivex Therapeutics' shares are currently sold short. Learn More on Enlivex Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENLV shares currently have a short interest ratio of 1.1. Learn More on Enlivex Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.26% of Enlivex Therapeutics' floating shares are currently sold short.

Enlivex Therapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 534,224 shares, a decrease of 2.0% from the previous total of 545,016 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.26% of Enlivex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enlivex Therapeutics: Alto Neuroscience, Inc. (5.60%), Esperion Therapeutics, Inc. (14.40%), Vor Biopharma Inc. (9.19%), Hyperliquid Strategies Inc (7.34%), Relmada Therapeutics, Inc. (5.96%), Inventiva S.A. Sponsored ADR (0.65%), Gyre Therapeutics, Inc. (1.81%), BioAge Labs, Inc. (5.36%), Solid Biosciences Inc. (10.36%), CytomX Therapeutics, Inc. (18.71%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling ENLV is an investing strategy that aims to generate trading profit from Enlivex Therapeutics as its price is falling. ENLV shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Enlivex Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENLV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENLV, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ENLV:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ENLV) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Is the SpaceX IPO “Rigged?”
The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...
The Oxford Club | Sponsoredtc pixel